Ibandronate as a treatment for bone pain in men with metastatic prostate cancer

A new report in the Journal of the National Cancer Institute suggests that a single intravenous injection of the drug ibandronate has a very similar ability to relieve prostate cancer-related bone pain as a single treatment with external beam radiation therapy. … READ MORE …

Prostate cancer news reports: Friday, August 14, 2009

Today’s news reports cover items on:

  • Patient understanding of the risks and benefits of active surveillance
  • Outcomes after RALP assessed using subjective and objective evalauation criteria
  • Viagra and post-surgical recovery of erectile function
  • Combining 153Sm-EDTMP and zoledronic acid to treat bone pain in patients with metastatic disease … READ MORE …

Skeletal complications and survival of HRPC patients

It is well understood that skeletal complications are a crucial factor in the quality of life and the prognosis of patients with hormone-refractory prostate cancer (HRPC); however, their true prevalence and impact on the prognosis remain largely unknown. … READ MORE …